Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
Per NivedGöran JönssonBo SettergrenJon EinarssonTor OlofssonCharlotte Sværke JørgensenLillemor SkattumMeliha C KapetanovicPublished in: Arthritis research & therapy (2020)
ClinicalTrials.gov, NCT03762824. Registered on 4 December 2018, retrospectively registered.